ES2171165T3 - Dispositivo bioerosionable para la administracion de agentes activos. - Google Patents

Dispositivo bioerosionable para la administracion de agentes activos.

Info

Publication number
ES2171165T3
ES2171165T3 ES94302638T ES94302638T ES2171165T3 ES 2171165 T3 ES2171165 T3 ES 2171165T3 ES 94302638 T ES94302638 T ES 94302638T ES 94302638 T ES94302638 T ES 94302638T ES 2171165 T3 ES2171165 T3 ES 2171165T3
Authority
ES
Spain
Prior art keywords
hours
bioerosionable
administration
active agents
active ingredient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES94302638T
Other languages
English (en)
Inventor
Peter Britton
William P Hart
Patricia Flanagan
Deborah Linkin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kenvue Brands LLC
Original Assignee
McNeil PPC Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by McNeil PPC Inc filed Critical McNeil PPC Inc
Application granted granted Critical
Publication of ES2171165T3 publication Critical patent/ES2171165T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S261/00—Gas and liquid contact apparatus
    • Y10S261/26—Foam

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

LA INVENCION SE REFIERE A UN DISPOSITIVO MUCO-ADHERENTE Y SOLUBLE PARA ADMINISTRAR INGREDIENTES ACTIVOS, A UN METODO PARA USO DE TAL DISPOSITIVO Y A UN METODO PERFECCIONADO PARA SU FABRICACION EMPLEANDO UN MEZCLADOR CONTINUO Y CERRADO CAPAZ DE OPERAR BAJO PRESION. LOS DISPOSITIVOS DE LA INVENCION, QUE COMPRENDE UNA ESPUMA LIOFILIZADA Y UN INGREDIENTE ACTIVO, TIENEN UN TIEMPO DE DISOLUCION DE 8 HORAS COMO MINIMO, Y PREFERIBLEMENTE DE 24 HORAS, Y PUEDEN PROPORCIONAR LA LIBERACION SOSTENIDA Y/O CONTROLADA DE UN INGREDIENTE ACTIVO DURANTE 24 HORAS.
ES94302638T 1993-08-16 1994-04-13 Dispositivo bioerosionable para la administracion de agentes activos. Expired - Lifetime ES2171165T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/104,785 US5458884A (en) 1992-09-10 1993-08-16 Bioerodible device for administering active ingredients

Publications (1)

Publication Number Publication Date
ES2171165T3 true ES2171165T3 (es) 2002-09-01

Family

ID=22302367

Family Applications (1)

Application Number Title Priority Date Filing Date
ES94302638T Expired - Lifetime ES2171165T3 (es) 1993-08-16 1994-04-13 Dispositivo bioerosionable para la administracion de agentes activos.

Country Status (8)

Country Link
US (1) US5458884A (es)
EP (1) EP0643963B1 (es)
KR (1) KR100277483B1 (es)
AT (1) ATE208612T1 (es)
DE (1) DE69429048T2 (es)
DK (1) DK0643963T3 (es)
ES (1) ES2171165T3 (es)
PT (1) PT643963E (es)

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2105887C (en) * 1992-09-10 2004-03-16 Peter Britton Bioerodible device for administering active ingredients
US6479457B2 (en) 1995-06-06 2002-11-12 Kinerton Limited Ionic molecular conjugates of N-acylated derivatives of poly(2-amino-2-deoxy-D-glucose) and polypeptides
US5656283A (en) * 1995-06-08 1997-08-12 Ortho Pharmaceutical Corporation In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product
US6416779B1 (en) * 1997-06-11 2002-07-09 Umd, Inc. Device and method for intravaginal or transvaginal treatment of fungal, bacterial, viral or parasitic infections
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6624200B2 (en) 1998-08-25 2003-09-23 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6248358B1 (en) 1998-08-25 2001-06-19 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets and methods of making and using the same
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US6475470B1 (en) 1998-09-25 2002-11-05 Kao Corporation Compositions for oral cavity
US6284262B1 (en) * 1999-01-26 2001-09-04 Virgil A. Place Compact dosage unit for buccal administration of a pharmacologically active agent
US6090401A (en) * 1999-03-31 2000-07-18 Mcneil-Ppc, Inc. Stable foam composition
SE514342C2 (sv) * 1999-05-31 2001-02-12 Nobel Biocare Ab Metod, anordning och användning vid implantat för att tillförsäkra tillförsel av bioaktiv substans till implantatets omgivande ben och/eller vävnad
US20020076440A1 (en) * 1999-06-25 2002-06-20 Thomas Leon Veterinary delivery systems and methods of delivering effective agents to animals
WO2001025322A1 (en) * 1999-10-05 2001-04-12 The Procter & Gamble Company Water unstable foam
GB2355014A (en) * 1999-10-05 2001-04-11 Procter & Gamble Foams and compositions containing these foams
MXPA02003447A (es) * 1999-10-05 2002-08-20 Procter & Gamble Articulos elasticos y usos de los mismos.
US6943200B1 (en) 1999-10-05 2005-09-13 Procter & Gamble Company Water unstable foam compositions
GB2355008A (en) * 1999-10-05 2001-04-11 Procter & Gamble Foam matrix coating material
US6555125B2 (en) 1999-11-30 2003-04-29 Phillip Campbell Lesion and ulcer medication
US6352711B1 (en) * 1999-11-30 2002-03-05 Phillip Campbell Lesion and ulcer medication
ATE344677T1 (de) * 2000-08-02 2006-11-15 Aesculap Ag & Co Kg Medizintechnisches produkt, verfahren zu seiner herstellung und bereitstellung für die chirurgie
US7198801B2 (en) 2000-08-03 2007-04-03 Antares Pharma Ipl Ag Formulations for transdermal or transmucosal application
ATE355854T1 (de) 2000-08-03 2007-03-15 Antares Pharma Ipl Ag Neue zusammensetzung zur transdermalen und/oder transmukosalen wirkstoffanwendung mit geeignetem therapeutischen spiegel
US8980290B2 (en) 2000-08-03 2015-03-17 Antares Pharma Ipl Ag Transdermal compositions for anticholinergic agents
GB2366797A (en) * 2000-09-13 2002-03-20 Procter & Gamble Process for making foam component by pressurising/depressurising
US6756051B1 (en) * 2000-11-15 2004-06-29 Li-Lan H. Chen Bioadhesive, closed-cell foam film, sustained release, delivery devices and methods of making and using same
EP1401352B1 (en) 2001-06-14 2012-03-21 Kenton W. Gregory Method for producing a chitosan wound dressing
US8741335B2 (en) 2002-06-14 2014-06-03 Hemcon Medical Technologies, Inc. Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as Chitosan
US7897832B2 (en) * 2001-06-14 2011-03-01 Hemcon Medical Technologies, Inc. Compositions, assemblies, and methods applied during or after a dental procedure to ameliorate fluid loss and/or promote healing, using a hydrophilic polymer sponge structure such as chitosan
US7371403B2 (en) 2002-06-14 2008-05-13 Providence Health System-Oregon Wound dressing and method for controlling severe, life-threatening bleeding
US8900497B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for making a film having a substantially uniform distribution of components
US8900498B2 (en) 2001-10-12 2014-12-02 Monosol Rx, Llc Process for manufacturing a resulting multi-layer pharmaceutical film
US8765167B2 (en) 2001-10-12 2014-07-01 Monosol Rx, Llc Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US8603514B2 (en) 2002-04-11 2013-12-10 Monosol Rx, Llc Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
US7357891B2 (en) 2001-10-12 2008-04-15 Monosol Rx, Llc Process for making an ingestible film
US10285910B2 (en) 2001-10-12 2019-05-14 Aquestive Therapeutics, Inc. Sublingual and buccal film compositions
US20070281003A1 (en) 2001-10-12 2007-12-06 Fuisz Richard C Polymer-Based Films and Drug Delivery Systems Made Therefrom
US20190328679A1 (en) 2001-10-12 2019-10-31 Aquestive Therapeutics, Inc. Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
US11207805B2 (en) 2001-10-12 2021-12-28 Aquestive Therapeutics, Inc. Process for manufacturing a resulting pharmaceutical film
US20110033542A1 (en) 2009-08-07 2011-02-10 Monosol Rx, Llc Sublingual and buccal film compositions
US8269058B2 (en) 2002-06-14 2012-09-18 Hemcon Medical Technologies, Inc. Absorbable tissue dressing assemblies, systems, and methods formed from hydrophilic polymer sponge structures such as chitosan
US20050137512A1 (en) 2003-12-23 2005-06-23 Campbell Todd D. Wound dressing and method for controlling severe, life-threatening bleeding
NZ540318A (en) * 2002-10-31 2007-09-28 Umd Inc Therapeutic compositions for drug delivery to and through covering epithelia
US20040151756A1 (en) * 2003-02-04 2004-08-05 Richards Anthony P. Edible low density high surface area drug vehicle, method of manufacturing low density high surface area drug vehicle
DK1670433T3 (da) 2003-10-10 2012-03-12 Ferring Bv Transdermal farmaceutisk formulering til mindskelse af hudrester
US7425340B2 (en) 2004-05-07 2008-09-16 Antares Pharma Ipl Ag Permeation enhancing compositions for anticholinergic agents
US9204957B2 (en) 2005-03-17 2015-12-08 Hemcon Medical Technologies, Inc. Systems and methods for hemorrhage control and or tissue repair
WO2006125642A1 (en) 2005-05-27 2006-11-30 Antares Pharma Ipl Ag Methods and apparatus for transdermal or transmucosal application of testosterone
CA2646667C (en) 2006-04-21 2014-03-11 Antares Pharma Ipl Ag Methods of treating hot flashes with formulations for transdermal or transmucosal application
WO2007139845A2 (en) 2006-05-23 2007-12-06 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center Systems and methods for introducing and applying a bandage structure within a body lumen or hollow body organ
WO2009134447A1 (en) 2008-05-02 2009-11-05 Providence Health System-Oregon D/B/A Providence St. Vincent Medical Center Wound dressing devices and methods
WO2010042540A1 (en) 2008-10-06 2010-04-15 Providence Health System - Oregon Foam medical devices and methods
US9149959B2 (en) 2010-10-22 2015-10-06 Monosol Rx, Llc Manufacturing of small film strips
US12433850B2 (en) 2016-05-05 2025-10-07 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine and prodrug compositions
KR20230137362A (ko) 2016-05-05 2023-10-04 어퀘스티브 테라퓨틱스, 아이엔씨. 강화된 전달 에프네프린 조성물
US12427121B2 (en) 2016-05-05 2025-09-30 Aquestive Therapeutics, Inc. Enhanced delivery epinephrine compositions
US11273131B2 (en) 2016-05-05 2022-03-15 Aquestive Therapeutics, Inc. Pharmaceutical compositions with enhanced permeation
DE102017112527B4 (de) * 2017-06-07 2019-01-03 Lts Lohmann Therapie-Systeme Ag Schnell zerfallende Schaumwafer mit hohem Flächengewicht
WO2021186982A1 (ja) * 2020-03-17 2021-09-23 日本たばこ産業株式会社 多孔質体の製造方法および多孔質体
EP4422607A4 (en) 2021-10-25 2025-09-03 Aquestive Therapeutics Inc ORAL AND NASAL COMPOSITIONS AND METHODS OF TREATMENT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4292972A (en) * 1980-07-09 1981-10-06 E. R. Squibb & Sons, Inc. Lyophilized hydrocolloio foam
US4642903A (en) * 1985-03-26 1987-02-17 R. P. Scherer Corporation Freeze-dried foam dosage form
FR2634376B1 (fr) * 1988-07-21 1992-04-17 Farmalyoc Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
US4948580A (en) * 1988-12-08 1990-08-14 E. R. Squibb & Sons, Inc. Muco-bioadhesive composition
US5039540A (en) * 1989-08-14 1991-08-13 Neophore Technologies, Inc. Freeze dry composition and method for oral administration of drugs, biologicals, nutrients and foodstuffs
DE4119140C2 (de) * 1991-06-11 1994-05-11 Merz & Co Gmbh & Co Poröser, in Körperflüssigkeiten und Sekreten löslicher, spongoider Formkörper, dessen Herstellung und Verwendung
US5354558A (en) * 1992-09-10 1994-10-11 Mcneil-Pcc, Inc. Bioerodible contraceptive suppository

Also Published As

Publication number Publication date
EP0643963A2 (en) 1995-03-22
KR100277483B1 (ko) 2001-09-17
DK0643963T3 (da) 2002-03-11
EP0643963B1 (en) 2001-11-14
DE69429048T2 (de) 2002-07-11
US5458884A (en) 1995-10-17
DE69429048D1 (de) 2001-12-20
EP0643963A3 (en) 1996-09-11
ATE208612T1 (de) 2001-11-15
KR940006574A (ko) 1994-04-25
PT643963E (pt) 2002-05-31

Similar Documents

Publication Publication Date Title
ES2171165T3 (es) Dispositivo bioerosionable para la administracion de agentes activos.
CA2105887A1 (en) Bioerodible device for administering active ingredients
MY100721A (en) Therapeutic agent.
BR9607752A (pt) Formulação farmacêutica de microcápsula de liberação controlada, processo para sua preparação, e, processo de uso das microcápsulas
HU900108D0 (en) Composition of controlled active ingredient delivery, operating by hydrogel
CA2004598A1 (en) Medicinal aerosol formulations
ES2009346A6 (es) Procedimiento de preparacion de composiciones farmaceuticas que contienen polipeptidos hidroinsolubles.
AU3990797A (en) Sustained release formulation
ITBO940379A0 (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rila- scio controllato del principio attivo.
PT918507E (pt) Formulacoes em aerossol
BR9503406A (pt) Formulaçoes farmacêuticas adaptadas para inhibir para perda de osso em um ser humano
IL86221A (en) Sustained release microencapsulated drugs and methods for the preparation thereof
WO1997042941A3 (en) Buccal delivery system
WO2001068038A3 (en) System for the controlled delivery of an active material to a dental site
CA2187353A1 (en) Liquid delivery compositions
ES2098920T3 (es) Formulaciones farmaceuticas para el tratamiento de la dependencia a la nicotina.
WO1999004772A3 (en) Use of levobupivacaine
ES2062137T3 (es) Utilizacion de 5'-deoxi-5'-metil-tioadenosina, s-adenosilmetionina y sus sales para la preparacion de composiciones farmaceuticas reductoras de seborrea.
ES2186207T3 (es) Metodo para preparacion de formulaciones farmaceuticas.
BR9404225A (pt) Formulação de substância ativa, aplicação, composições, medicamentos e processo para a preparação das formulações
HUT75029A (en) Systems for controlled release of pilocarpine, and semipermeable capsule containing the active ingredient
EP0744176A3 (en) Methods for inhibiting bone loss
HUT50787A (en) Process for producing pharmaceutical compositions comprising 4-aryl-4-piperidine-, pyrrolidine- or hexahydroazepincarbinol derivatives or heterocyclic analogs thereof as active ingredient and process for producing the new compounds
HU9700842D0 (en) Pharmaceutical compositions based on stabilized lipophyl matrix giving controlled release for the active components
EP0373771A3 (en) New pharmaceutical uses for cystatins

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 643963

Country of ref document: ES